InsiderTrades

Form 4 for CELU Celularity Inc

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-17 · accession 0001493152-25-007599 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-19 2025-02-17 CELU Beers David C CFO F - Tax $2.14 -4,396 17.5K -20% -$9,407
D 2025-02-19 2025-02-17 CELU Beers David C CFO M - OptEx $0.00 +12.5K 21.9K +133% $0
D 2025-02-19 2025-02-17 CELU Beers David C CFO M - OptEx $0.00 -12.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-02-17 F D 4,396 $2.14 17,536 D — —
2 Common Class A Common Stock 2025-02-17 M A 12,500 $0.00 21,932 D — — (F1) Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22,2023.
3 Derivative Restricted Stock Units 2025-02-17 M D 12,500 $0.00 0 D — · — to — 12,500 Class A Common Stock (F3) Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. (F4) On February 17, 2023, the reporting person was granted 12,500 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4.